APO Research
Talk to an analyst

APO RESEARCH · REPORT

Classical Swine Fever Vaccines

It is a type of vaccine for classical swine fever. Classical swine fever (CSF), also known as hog cholera, is a contagious viral disease of pigs, including wild boar. The causative virus is a member of the genus Pestivirus of the family Flaviviridae, and is closely related to the viruses of bovine viral diarrhoea and border disease. There is only one serotype of CSF virus (CSFV).

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

It is a type of vaccine for classical swine fever. Classical swine fever (CSF), also known as hog cholera, is a contagious viral disease of pigs, including wild boar. The causative virus is a member of the genus Pestivirus of the family Flaviviridae, and is closely related to the viruses of bovine viral diarrhoea and border disease. There is only one serotype of CSF virus (CSFV).

Selected research

Market Analysis & Forecast

Global Classical Swine Fever Vaccines Market Analysis and Forecast 2026-2032

21 December 2025206 pages

Choose your research edition.

Industry ResearchClassical Swine Fever Vaccines Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Classical Swine Fever Vaccines Industry Growth and Trends Forecast to 2032115 pages · $3,450 USDMarket StructureGlobal Classical Swine Fever Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Classical Swine Fever Vaccines Market Outlook and Growth Opportunities 2026200 pages · $4,250 USDMarket Analysis & ForecastGlobal Classical Swine Fever Vaccines Market Analysis and Forecast 2026-2032206 pages · $4,950 USD

Market perspective

It is a type of vaccine for classical swine fever. Classical swine fever (CSF), also known as hog cholera, is a contagious viral disease of pigs, including wild boar. The causative virus is a member of the genus Pestivirus of the family Flaviviridae, and is closely related to the viruses of bovine viral diarrhoea and border disease. There is only one serotype of CSF virus (CSFV).

The global classical swine fever vaccine market is dominated by Winsun, Merial and CAHIC, with the top three manufacturers accounting for about 60% of the market share. Asia Pacific is the largest market for classical swine fever vaccines, with a market share of about 50%, followed by Europe with a market share of about 25%. Tissue Culture Origin is the main type, with a share about 60%. Market Sales is the main application, which holds a share about 95%.

This report presents an overview of global market for Classical Swine Fever Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

Read the full market overview

This report researches the key producers of Classical Swine Fever Vaccines, also provides the sales of main regions and countries. Of the upcoming market potential for Classical Swine Fever Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Classical Swine Fever Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Classical Swine Fever Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Classical Swine Fever Vaccines sales, projected growth trends, production technology, application and end-user industry.

Classical Swine Fever Vaccines Segment by Company

WINSUN

Merial

CAHIC

Chopper Biology

MSD Animal Health (Merck)

ChengDu Tecbond

Ceva

Harbin Veterinary Research Institute

Qilu Animal Health Products Factory

Ringpu Biology

DHN

CAVAC

Komipharm

Agrovet

Bioveta

Jinyu Bio-Technology

Institutul Pasteur

MVP

Tecon

Classical Swine Fever Vaccines Segment by Source

Tissue Culture Origin

Cell Line Origin

Classical Swine Fever Vaccines Segment by Sales Channel

Government Tender

Market Sales

Classical Swine Fever Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Classical Swine Fever Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Classical Swine Fever Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Classical Swine Fever Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Classical Swine Fever Vaccines in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Classical Swine Fever Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Classical Swine Fever Vaccines sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Classical Swine Fever Vaccines Market Size Growth Rate by Source (US$ Million), 2021 VS 2025 VS 2032 Table 2. Tissue Culture Origin Major Manufacturers Table 3. Cell Line Origin Major Manufacturers Table 4. Global Classical Swine Fever Vaccines Market Size Growth Rate by Sales Channel (US$ Million), 2021 VS 2025 VS 2032 Table 5. Government Tender Major Manufacturers Table 6. Market Sales Major Manufacturers Table 7. Classical Swine Fever Vaccines Industry Trends Table 8. Classical Swine Fever Vaccines Industry Drivers Table 9. Classical Swine Fever Vaccines Industry Opportunities and Challenges Table 10. Classical Swine Fever Vaccines Industry Restraints Table 11. Global Classical Swine Fever Vaccines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Classical Swine Fever Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Classical Swine Fever Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Classical Swine Fever Vaccines Revenue Market Share by Region (2021-2026) Table 15. Global Classical Swine Fever Vaccines Revenue Market Share by Region (2027-2032) Table 16. Global Classical Swine Fever Vaccines Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (M Doses) Table 17. Global Classical Swine Fever Vaccines Sales by Region (2021-2026) & (M Doses) Table 18. Global Classical Swine Fever Vaccines Sales by Region (2027-2032) & (M Doses) Table 19. Global Classical Swine Fever Vaccines Sales Market Share by Region (2021-2026) Table 20. Global Classical Swine Fever Vaccines Sales Market Share by Region (2027-2032) Table 21. Global Classical Swine Fever Vaccines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Classical Swine Fever Vaccines Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Classical Swine Fever Vaccines Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Classical Swine Fever Vaccines Sales Market Share by Manufacturers (2021-2026) Table 25. Global Classical Swine Fever Vaccines Sales Price (US$/K Doses) of Manufacturers (2021-2026) Table 26. Global Classical Swine Fever Vaccines Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Classical Swine Fever Vaccines Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Classical Swine Fever Vaccines Manufacturers, Product Type & Application Table 29. Global Classical Swine Fever Vaccines Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Classical Swine Fever Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Classical Swine Fever Vaccines Revenue by Source 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Classical Swine Fever Vaccines Revenue by Source (2021-2026) & (US$ Million) Table 34. Global Classical Swine Fever Vaccines Revenue by Source (2027-2032) & (US$ Million) Table 35. Global Classical Swine Fever Vaccines Revenue Market Share by Source (2021-2026) Table 36. Global Classical Swine Fever Vaccines Revenue Market Share by Source (2027-2032) Table 37. Global Classical Swine Fever Vaccines Sales by Source 2021 VS 2025 VS 2032 (M Doses) Table 38. Global Classical Swine Fever Vaccines Sales by Source (2021-2026) & (M Doses) Table 39. Global Classical Swine Fever Vaccines Sales by Source (2027-2032) & (M Doses) Table 40. Global Classical Swine Fever Vaccines Sales Market Share by Source (2021-2026) Table 41. Global Classical Swine Fever Vaccines Sales Market Share by Source (2027-2032) Table 42. Global Classical Swine Fever Vaccines Price by Source (2021-2026) & (US$/K Doses) Table 43. Global Classical Swine Fever Vaccines Price by Source (2027-2032) & (US$/K Doses) Table 44. Global Classical Swine Fever Vaccines Revenue by Sales Channel 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Classical Swine Fever Vaccines Revenue by Sales Channel (2021-2026) & (US$ Million) Table 46. Global Classical Swine Fever Vaccines Revenue by Sales Channel (2027-2032) & (US$ Million) Table 47. Global Classical Swine Fever Vaccines Revenue Market Share by Sales Channel (2021-2026) Table 48. Global Classical Swine Fever Vaccines Revenue Market Share by Sales Channel (2027-2032) Table 49. Global Classical Swine Fever Vaccines Sales by Sales Channel 2021 VS 2025 VS 2032 (M Doses) Table 50. Global Classical Swine Fever Vaccines Sales by Sales Channel (2021-2026) & (M Doses) Table 51. Global Classical Swine Fever Vaccines Sales by Sales Channel (2027-2032) & (M Doses) Table 52. Global Classical Swine Fever Vaccines Sales Market Share by Sales Channel (2021-2026) Table 53. Global Classical Swine Fever Vaccines Sales Market Share by Sales Channel (2027-2032) Table 54. Global Classical Swine Fever Vaccines Price by Sales Channel (2021-2026) & (US$/K Doses) Table 55. Global Classical Swine Fever Vaccines Price by Sales Channel (2027-2032) & (US$/K Doses) Table 56. WINSUN Company Information Table 57. WINSUN Business Overview Table 58. WINSUN Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2021-2026) Table 59. WINSUN Classical Swine Fever Vaccines Product Portfolio Table 60. WINSUN Recent Development Table 61. Merial Company Information Table 62. Merial Business Overview Table 63. Merial Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2021-2026) Table 64. Merial Classical Swine Fever Vaccines Product Portfolio Table 65. Merial Recent Development Table 66. CAHIC Company Information Table 67. CAHIC Business Overview Table 68. CAHIC Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2021-2026) Table 69. CAHIC Classical Swine Fever Vaccines Product Portfolio Table 70. CAHIC Recent Development Table 71. Chopper Biology Company Information Table 72. Chopper Biology Business Overview Table 73. Chopper Biology Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2021-2026) Table 74. Chopper Biology Classical Swine Fever Vaccines Product Portfolio Table 75. Chopper Biology Recent Development Table 76. MSD Animal Health (Merck) Company Information Table 77. MSD Animal Health (Merck) Business Overview Table 78. MSD Animal Health (Merck) Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2021-2026) Table 79. MSD Animal Health (Merck) Classical Swine Fever Vaccines Product Portfolio Table 80. MSD Animal Health (Merck) Recent Development Table 81. ChengDu Tecbond Company Information Table 82. ChengDu Tecbond Business Overview Table 83. ChengDu Tecbond Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2021-2026) Table 84. ChengDu Tecbond Classical Swine Fever Vaccines Product Portfolio Table 85. ChengDu Tecbond Recent Development Table 86. Ceva Company Information Table 87. Ceva Business Overview Table 88. Ceva Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2021-2026) Table 89. Ceva Classical Swine Fever Vaccines Product Portfolio Table 90. Ceva Recent Development Table 91. Harbin Veterinary Research Institute Company Information Table 92. Harbin Veterinary Research Institute Business Overview Table 93. Harbin Veterinary Research Institute Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2021-2026) Table 94. Harbin Veterinary Research Institute Classical Swine Fever Vaccines Product Portfolio Table 95. Harbin Veterinary Research Institute Recent Development Table 96. Qilu Animal Health Products Factory Company Information Table 97. Qilu Animal Health Products Factory Business Overview Table 98. Qilu Animal Health Products Factory Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2021-2026) Table 99. Qilu Animal Health Products Factory Classical Swine Fever Vaccines Product Portfolio Table 100. Qilu Animal Health Products Factory Recent Development Table 101. Ringpu Biology Company Information Table 102. Ringpu Biology Business Overview Table 103. Ringpu Biology Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2021-2026) Table 104. Ringpu Biology Classical Swine Fever Vaccines Product Portfolio Table 105. Ringpu Biology Recent Development Table 106. DHN Company Information Table 107. DHN Business Overview Table 108. DHN Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2021-2026) Table 109. DHN Classical Swine Fever Vaccines Product Portfolio Table 110. DHN Recent Development Table 111. CAVAC Company Information Table 112. CAVAC Business Overview Table 113. CAVAC Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2021-2026) Table 114. CAVAC Classical Swine Fever Vaccines Product Portfolio Table 115. CAVAC Recent Development Table 116. Komipharm Company Information Table 117. Komipharm Business Overview Table 118. Komipharm Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2021-2026) Table 119. Komipharm Classical Swine Fever Vaccines Product Portfolio Table 120. Komipharm Recent Development Table 121. Agrovet Company Information Table 122. Agrovet Business Overview Table 123. Agrovet Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2021-2026) Table 124. Agrovet Classical Swine Fever Vaccines Product Portfolio Table 125. Agrovet Recent Development Table 126. Bioveta Company Information Table 127. Bioveta Business Overview Table 128. Bioveta Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2021-2026) Table 129. Bioveta Classical Swine Fever Vaccines Product Portfolio Table 130. Bioveta Recent Development Table 131. Jinyu Bio-Technology Company Information Table 132. Jinyu Bio-Technology Business Overview Table 133. Jinyu Bio-Technology Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2021-2026) Table 134. Jinyu Bio-Technology Classical Swine Fever Vaccines Product Portfolio Table 135. Jinyu Bio-Technology Recent Development Table 136. Institutul Pasteur Company Information Table 137. Institutul Pasteur Business Overview Table 138. Institutul Pasteur Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2021-2026) Table 139. Institutul Pasteur Classical Swine Fever Vaccines Product Portfolio Table 140. Institutul Pasteur Recent Development Table 141. MVP Company Information Table 142. MVP Business Overview Table 143. MVP Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2021-2026) Table 144. MVP Classical Swine Fever Vaccines Product Portfolio Table 145. MVP Recent Development Table 146. Tecon Company Information Table 147. Tecon Business Overview Table 148. Tecon Classical Swine Fever Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/K Doses) and Gross Margin (2021-2026) Table 149. Tecon Classical Swine Fever Vaccines Product Portfolio Table 150. Tecon Recent Development Table 151. North America Classical Swine Fever Vaccines Revenue by Source (2021-2026) & (US$ Million) Table 152. North America Classical Swine Fever Vaccines Revenue by Source (2027-2032) & (US$ Million) Table 153. North America Classical Swine Fever Vaccines Sales by Source (2021-2026) & (M Doses) Table 154. North America Classical Swine Fever Vaccines Sales by Source (2027-2032) & (M Doses) Table 155. North America Classical Swine Fever Vaccines Sales Price by Source (2021-2026) & (US$/K Doses) Table 156. North America Classical Swine Fever Vaccines Sales Price by Source (2027-2032) & (US$/K Doses) Table 157. North America Classical Swine Fever Vaccines Revenue by Sales Channel (2021-2026) & (US$ Million) Table 158. North America Classical Swine Fever Vaccines Revenue by Sales Channel (2027-2032) & (US$ Million) Table 159. North America Classical Swine Fever Vaccines Sales by Sales Channel (2021-2026) & (M Doses) Table 160. North America Classical Swine Fever Vaccines Sales by Sales Channel (2027-2032) & (M Doses) Table 161. North America Classical Swine Fever Vaccines Sales Price by Sales Channel (2021-2026) & (US$/K Doses) Table 162. North America Classical Swine Fever Vaccines Sales Price by Sales Channel (2027-2032) & (US$/K Doses) Table 163. North America Classical Swine Fever Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 164. North America Classical Swine Fever Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 165. North America Classical Swine Fever Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 166. North America Classical Swine Fever Vaccines Sales by Country (2021 VS 2025 VS 2032) & (M Doses) Table 167. North America Classical Swine Fever Vaccines Sales by Country (2021-2026) & (M Doses) Table 168. North America Classical Swine Fever Vaccines Sales by Country (2027-2032) & (M Doses) Table 169. North America Classical Swine Fever Vaccines Sales Price by Country (2021-2026) & (US$/K Doses) Table 170. North America Classical Swine Fever Vaccines Sales Price by Country (2027-2032) & (US$/K Doses) Table 171. United States Classical Swine Fever Vaccines Revenue (2021-2032) & (US$ Million) Table 172. Canada Classical Swine Fever Vaccines Revenue (2021-2032) & (US$ Million) Table 173. Mexico Classical Swine Fever Vaccines Revenue (2021-2032) & (US$ Million) Table 174. Europe Classical Swine Fever Vaccines Revenue by Source (2021-2026) & (US$ Million) Table 175. Europe Classical Swine Fever Vaccines Revenue by Source (2027-2032) & (US$ Million) Table 176. Europe Classical Swine Fever Vaccines Sales by Source (2021-2026) & (M Doses) Table 177. Europe Classical Swine Fever Vaccines Sales by Source (2027-2032) & (M Doses) Table 178. Europe Classical Swine Fever Vaccines Sales Price by Source (2021-2026) & (US$/K Doses) Table 179. Europe Classical Swine Fever Vaccines Sales Price by Source (2027-2032) & (US$/K Doses) Table 180. Europe Classical Swine Fever Vaccines Revenue by Sales Channel (2021-2026) & (US$ Million) Table 181. Europe Classical Swine Fever Vaccines Revenue by Sales Channel (2027-2032) & (US$ Million) Table 182. Europe Classical Swine Fever Vaccines Sales by Sales Channel (2021-2026) & (M Doses) Table 183. Europe Classical Swine Fever Vaccines Sales by Sales Channel (2027-2032) & (M Doses) Table 184. Europe Classical Swine Fever Vaccines Sales Price by Sales Channel (2021-2026) & (US$/K Doses) Table 185. Europe Classical Swine Fever Vaccines Sales Price by Sales Channel (2027-2032) & (US$/K Doses) Table 186. Europe Classical Swine Fever Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 187. Europe Classical Swine Fever Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 188. Europe Classical Swine Fever Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 189. Europe Classical Swine Fever Vaccines Sales by Country (2021 VS 2025 VS 2032) & (M Doses) Table 190. Europe Classical Swine Fever Vaccines Sales by Country (2021-2026) & (M Doses) Table 191. Europe Classical Swine Fever Vaccines Sales by Country (2027-2032) & (M Doses) Table 192. Europe Classical Swine Fever Vaccines Sales Price by Country (2021-2026) & (US$/K Doses) Table 193. Europe Classical Swine Fever Vaccines Sales Price by Country (2027-2032) & (US$/K Doses) Table 194. Germany Classical Swine Fever Vaccines Revenue (2021-2032) & (US$ Million) Table 195. France Classical Swine Fever Vaccines Revenue (2021-2032) & (US$ Million) Table 196. U.K. Classical Swine Fever Vaccines Revenue (2021-2032) & (US$ Million) Table 197. Italy Classical Swine Fever Vaccines Revenue (2021-2032) & (US$ Million) Table 198. Russia Classical Swine Fever Vaccines Revenue (2021-2032) & (US$ Million) Table 199. Spain Classical Swine Fever Vaccines Revenue (2021-2032) & (US$ Million) Table 200. Netherlands Classical Swine Fever Vaccines Revenue (2021-2032) & (US$ Million) Table 201. Switzerland Classical Swine Fever Vaccines Revenue (2021-2032) & (US$ Million) Table 202. Sweden Classical Swine Fever Vaccines Revenue (2021-2032) & (US$ Million) Table 203. Poland Classical Swine Fever Vaccines Revenue (2021-2032) & (US$ Million) Table 204. China Classical Swine Fever Vaccines Revenue by Source (2021-2026) & (US$ Million) Table 205. China Classical Swine Fever Vaccines Revenue by Source (2027-2032) & (US$ Million) Table 206. China Classical Swine Fever Vaccines Sales by Source (2021-2026) & (M Doses) Table 207. China Classical Swine Fever Vaccines Sales by Source (2027-2032) & (M Doses) Table 208. China Classical Swine Fever Vaccines Sales Price by Source (2021-2026) & (US$/K Doses) Table 209. China Classical Swine Fever Vaccines Sales Price by Source (2027-2032) & (US$/K Doses) Table 210. China Classical Swine Fever Vaccines Revenue by Sales Channel (2021-2026) & (US$ Million) Table 211. China Classical Swine Fever Vaccines Revenue by Sales Channel (2027-2032) & (US$ Million) Table 212. China Classical Swine Fever Vaccines Sales by Sales Channel (2021-2026) & (M Doses) Table 213. China Classical Swine Fever Vaccines Sales by Sales Channel (2027-2032) & (M Doses) Table 214. China Classical Swine Fever Vaccines Sales Price by Sales Channel (2021-2026) & (US$/K Doses) Table 215. China Classical Swine Fever Vaccines Sales Price by Sales Channel (2027-2032) & (US$/K Doses) Table 216. Asia Classical Swine Fever Vaccines Revenue by Source (2021-2026) & (US$ Million) Table 217. Asia Classical Swine Fever Vaccines Revenue by Source (2027-2032) & (US$ Million) Table 218. Asia Classical Swine Fever Vaccines Sales by Source (2021-2026) & (M Doses) Table 219. Asia Classical Swine Fever Vaccines Sales by Source (2027-2032) & (M Doses) Table 220. Asia Classical Swine Fever Vaccines Sales Price by Source (2021-2026) & (US$/K Doses) Table 221. Asia Classical Swine Fever Vaccines Sales Price by Source (2027-2032) & (US$/K Doses) Table 222. Asia Classical Swine Fever Vaccines Revenue by Sales Channel (2021-2026) & (US$ Million) Table 223. Asia Classical Swine Fever Vaccines Revenue by Sales Channel (2027-2032) & (US$ Million) Table 224. Asia Classical Swine Fever Vaccines Sales by Sales Channel (2021-2026) & (M Doses) Table 225. Asia Classical Swine Fever Vaccines Sales by Sales Channel (2027-2032) & (M Doses) Table 226. Asia Classical Swine Fever Vaccines Sales Price by Sales Channel (2021-2026) & (US$/K Doses) Table 227. Asia Classical Swine Fever Vaccines Sales Price by Sales Channel (2027-2032) & (US$/K Doses) Table 228. Asia Classical Swine Fever Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 229. Asia Classical Swine Fever Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 230. Asia Classical Swine Fever Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 231. Asia Classical Swine Fever Vaccines Sales by Country (2021 VS 2025 VS 2032) & (M Doses) Table 232. Asia Classical Swine Fever Vaccines Sales by Country (2021-2026) & (M Doses) Table 233. Asia Classical Swine Fever Vaccines Sales by Country (2027-2032) & (M Doses) Table 234. Asia Classical Swine Fever Vaccines Sales Price by Country (2021-2026) & (US$/K Doses) Table 235. Asia Classical Swine Fever Vaccines Sales Price by Country (2027-2032) & (US$/K Doses) Table 236. Japan Classical Swine Fever Vaccines Revenue (2021-2032) & (US$ Million) Table 237. South Korea Classical Swine Fever Vaccines Revenue (2021-2032) & (US$ Million) Table 238. India Classical Swine Fever Vaccines Revenue (2021-2032) & (US$ Million) Table 239. Australia Classical Swine Fever Vaccines Revenue (2021-2032) & (US$ Million) Table 240. Taiwan Classical Swine Fever Vaccines Revenue (2021-2032) & (US$ Million) Table 241. Southeast Asia Classical Swine Fever Vaccines Revenue (2021-2032) & (US$ Million) Table 242. SAMEA Classical Swine Fever Vaccines Revenue by Source (2021-2026) & (US$ Million) Table 243. SAMEA Classical Swine Fever Vaccines Revenue by Source (2027-2032) & (US$ Million) Table 244. SAMEA Classical Swine Fever Vaccines Sales by Source (2021-2026) & (M Doses) Table 245. SAMEA Classical Swine Fever Vaccines Sales by Source (2027-2032) & (M Doses) Table 246. SAMEA Classical Swine Fever Vaccines Sales Price by Source (2021-2026) & (US$/K Doses) Table 247. SAMEA Classical Swine Fever Vaccines Sales Price by Source (2027-2032) & (US$/K Doses) Table 248. SAMEA Classical Swine Fever Vaccines Revenue by Sales Channel (2021-2026) & (US$ Million) Table 249. SAMEA Classical Swine Fever Vaccines Revenue by Sales Channel (2027-2032) & (US$ Million) Table 250. SAMEA Classical Swine Fever Vaccines Sales by Sales Channel (2021-2026) & (M Doses) Table 251. SAMEA Classical Swine Fever Vaccines Sales by Sales Channel (2027-2032) & (M Doses) Table 252. SAMEA Classical Swine Fever Vaccines Sales Price by Sales Channel (2021-2026) & (US$/K Doses) Table 253. SAMEA Classical Swine Fever Vaccines Sales Price by Sales Channel (2027-2032) & (US$/K Doses) Table 254. SAMEA Classical Swine Fever Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 255. SAMEA Classical Swine Fever Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 256. SAMEA Classical Swine Fever Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 257. SAMEA Classical Swine Fever Vaccines Sales by Country (2021 VS 2025 VS 2032) & (M Doses) Table 258. SAMEA Classical Swine Fever Vaccines Sales by Country (2021-2026) & (M Doses) Table 259. SAMEA Classical Swine Fever Vaccines Sales by Country (2027-2032) & (M Doses) Table 260. SAMEA Classical Swine Fever Vaccines Sales Price by Country (2021-2026) & (US$/K Doses) Table 261. SAMEA Classical Swine Fever Vaccines Sales Price by Country (2027-2032) & (US$/K Doses) Table 262. Brazil Classical Swine Fever Vaccines Revenue (2021-2032) & (US$ Million) Table 263. Argentina Classical Swine Fever Vaccines Revenue (2021-2032) & (US$ Million) Table 264. Chile Classical Swine Fever Vaccines Revenue (2021-2032) & (US$ Million) Table 265. Colombia Classical Swine Fever Vaccines Revenue (2021-2032) & (US$ Million) Table 266. Peru Classical Swine Fever Vaccines Revenue (2021-2032) & (US$ Million) Table 267. Saudi Arabia Classical Swine Fever Vaccines Revenue (2021-2032) & (US$ Million) Table 268. Israel Classical Swine Fever Vaccines Revenue (2021-2032) & (US$ Million) Table 269. UAE Classical Swine Fever Vaccines Revenue (2021-2032) & (US$ Million) Table 270. Turkey Classical Swine Fever Vaccines Revenue (2021-2032) & (US$ Million) Table 271. Iran Classical Swine Fever Vaccines Revenue (2021-2032) & (US$ Million) Table 272. Egypt Classical Swine Fever Vaccines Revenue (2021-2032) & (US$ Million) Table 273. Key Raw Materials Table 274. Raw Materials Key Suppliers Table 275. Classical Swine Fever Vaccines Distributors List Table 276. Classical Swine Fever Vaccines Customers List Table 277. Research Programs/Design for This Report Table 278. Authors List of This Report Table 279. Secondary Sources Table 280. Primary Sources List of Figures Figure 1. Classical Swine Fever Vaccines Image Figure 2. Global Classical Swine Fever Vaccines Market Size Growth Rate by Source (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Classical Swine Fever Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 4. Tissue Culture Origin Image Figure 5. Cell Line Origin Image Figure 6. Global Classical Swine Fever Vaccines Market Size Growth Rate by Sales Channel (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Classical Swine Fever Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 8. Government Tender Image Figure 9. Market Sales Image Figure 10. Global Classical Swine Fever Vaccines Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Classical Swine Fever Vaccines Revenue (2021-2032) & (US$ Million) Figure 12. Global Classical Swine Fever Vaccines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Classical Swine Fever Vaccines Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Classical Swine Fever Vaccines Revenue Market Share by Region (2021-2032) Figure 15. Global Classical Swine Fever Vaccines Sales (2021-2032) & (M Doses) Figure 16. Global Classical Swine Fever Vaccines Sales by Region: 2021 VS 2025 VS 2032 (M Doses) Figure 17. Global Classical Swine Fever Vaccines Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Classical Swine Fever Vaccines Sales YoY (2021-2032) & (M Doses) Figure 19. Europe Classical Swine Fever Vaccines Sales YoY (2021-2032) & (M Doses) Figure 20. China Classical Swine Fever Vaccines Sales YoY (2021-2032) & (M Doses) Figure 21. Asia (Excluding China) Classical Swine Fever Vaccines Sales YoY (2021-2032) & (M Doses) Figure 22. South America, Middle East and Africa Classical Swine Fever Vaccines Sales YoY (2021-2032) & (M Doses) Figure 23. Global Classical Swine Fever Vaccines Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Classical Swine Fever Vaccines Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Classical Swine Fever Vaccines Revenue by Source (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Classical Swine Fever Vaccines Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Classical Swine Fever Vaccines Revenue Market Share by Source (2021-2032) Figure 29. Global Classical Swine Fever Vaccines Sales by Source (2021 VS 2025 VS 2032) & (M Doses) Figure 30. Global Classical Swine Fever Vaccines Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Classical Swine Fever Vaccines Sales Market Share by Source (2021-2032) Figure 32. Global Classical Swine Fever Vaccines Revenue by Sales Channel (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Classical Swine Fever Vaccines Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Classical Swine Fever Vaccines Revenue Market Share by Sales Channel (2021-2032) Figure 35. Global Classical Swine Fever Vaccines Sales by Sales Channel (2021 VS 2025 VS 2032) & (M Doses) Figure 36. Global Classical Swine Fever Vaccines Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Classical Swine Fever Vaccines Sales Market Share by Sales Channel (2021-2032) Figure 38. North America Classical Swine Fever Vaccines Revenue Share by Source (2021-2032) Figure 39. North America Classical Swine Fever Vaccines Sales Share by Source (2021-2032) Figure 40. North America Classical Swine Fever Vaccines Revenue Share by Sales Channel (2021-2032) Figure 41. North America Classical Swine Fever Vaccines Sales Share by Sales Channel (2021-2032) Figure 42. North America Classical Swine Fever Vaccines Revenue Share by Country (2021-2032) Figure 43. North America Classical Swine Fever Vaccines Sales Share by Country (2021-2032) Figure 44. Europe Classical Swine Fever Vaccines Revenue Share by Source (2021-2032) Figure 45. Europe Classical Swine Fever Vaccines Sales Share by Source (2021-2032) Figure 46. Europe Classical Swine Fever Vaccines Revenue Share by Sales Channel (2021-2032) Figure 47. Europe Classical Swine Fever Vaccines Sales Share by Sales Channel (2021-2032) Figure 48. Europe Classical Swine Fever Vaccines Revenue Share by Country (2021-2032) Figure 49. Europe Classical Swine Fever Vaccines Sales Share by Country (2021-2032) Figure 50. China Classical Swine Fever Vaccines Revenue Share by Source (2021-2032) Figure 51. China Classical Swine Fever Vaccines Sales Share by Source (2021-2032) Figure 52. China Classical Swine Fever Vaccines Revenue Share by Sales Channel (2021-2032) Figure 53. China Classical Swine Fever Vaccines Sales Share by Sales Channel (2021-2032) Figure 54. Asia Classical Swine Fever Vaccines Revenue Share by Source (2021-2032) Figure 55. Asia Classical Swine Fever Vaccines Sales Share by Source (2021-2032) Figure 56. Asia Classical Swine Fever Vaccines Revenue Share by Sales Channel (2021-2032) Figure 57. Asia Classical Swine Fever Vaccines Sales Share by Sales Channel (2021-2032) Figure 58. Asia Classical Swine Fever Vaccines Revenue Share by Country (2021-2032) Figure 59. Asia Classical Swine Fever Vaccines Sales Share by Country (2021-2032) Figure 60. SAMEA Classical Swine Fever Vaccines Revenue Share by Source (2021-2032) Figure 61. SAMEA Classical Swine Fever Vaccines Sales Share by Source (2021-2032) Figure 62. SAMEA Classical Swine Fever Vaccines Revenue Share by Sales Channel (2021-2032) Figure 63. SAMEA Classical Swine Fever Vaccines Sales Share by Sales Channel (2021-2032) Figure 64. SAMEA Classical Swine Fever Vaccines Revenue Share by Country (2021-2032) Figure 65. SAMEA Classical Swine Fever Vaccines Sales Share by Country (2021-2032) Figure 66. Classical Swine Fever Vaccines Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Classical Swine Fever Vaccines Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Tissue Culture Origin
  • Cell Line Origin
Applications
  • Government Tender
  • Market Sales
Companies covered
  • WINSUN
  • Merial
  • CAHIC
  • Chopper Biology
  • MSD Animal Health (Merck)
  • ChengDu Tecbond
  • Ceva
  • Harbin Veterinary Research Institute
  • Qilu Animal Health Products Factory
  • Ringpu Biology
  • DHN
  • CAVAC
  • Komipharm
  • Agrovet
  • Bioveta
  • Jinyu Bio-Technology
  • Institutul Pasteur
  • MVP
  • Tecon

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Classical Swine Fever Vaccines Market by Source
  3. 1.2.1 Global Classical Swine Fever Vaccines Market Size by Source, 2021 VS 2025 VS 2032
  4. 1.2.2 Tissue Culture Origin
  5. 1.2.3 Cell Line Origin
  6. 1.3 Classical Swine Fever Vaccines Market by Sales Channel
  7. 1.3.1 Global Classical Swine Fever Vaccines Market Size by Sales Channel, 2021 VS 2025 VS 2032
  8. 1.3.2 Government Tender
  9. 1.3.3 Market Sales
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Classical Swine Fever Vaccines Market Dynamics
  1. 2.1 Classical Swine Fever Vaccines Industry Trends
  2. 2.2 Classical Swine Fever Vaccines Industry Drivers
  3. 2.3 Classical Swine Fever Vaccines Industry Opportunities and Challenges
  4. 2.4 Classical Swine Fever Vaccines Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Classical Swine Fever Vaccines Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Classical Swine Fever Vaccines Revenue by Region
  3. 3.2.1 Global Classical Swine Fever Vaccines Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Classical Swine Fever Vaccines Revenue by Region (2021-2026)
  5. 3.2.3 Global Classical Swine Fever Vaccines Revenue by Region (2027-2032)
  6. 3.2.4 Global Classical Swine Fever Vaccines Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Classical Swine Fever Vaccines Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Classical Swine Fever Vaccines Sales by Region
  9. 3.4.1 Global Classical Swine Fever Vaccines Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Classical Swine Fever Vaccines Sales by Region (2021-2026)
  11. 3.4.3 Global Classical Swine Fever Vaccines Sales by Region (2027-2032)
  12. 3.4.4 Global Classical Swine Fever Vaccines Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Classical Swine Fever Vaccines Revenue by Manufacturers
  2. 4.1.1 Global Classical Swine Fever Vaccines Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Classical Swine Fever Vaccines Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Classical Swine Fever Vaccines Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Classical Swine Fever Vaccines Sales by Manufacturers
  6. 4.2.1 Global Classical Swine Fever Vaccines Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Classical Swine Fever Vaccines Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Classical Swine Fever Vaccines Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Classical Swine Fever Vaccines Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Classical Swine Fever Vaccines Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Classical Swine Fever Vaccines Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Classical Swine Fever Vaccines Manufacturers, Product Type & Application
  13. 4.7 Global Classical Swine Fever Vaccines Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Classical Swine Fever Vaccines Market CR5 and HHI
  16. 4.8.2 2025 Classical Swine Fever Vaccines Tier 1, Tier 2, and Tier 3
5 Classical Swine Fever Vaccines Market by Type
  1. 5.1 Global Classical Swine Fever Vaccines Revenue by Type
  2. 5.1.1 Global Classical Swine Fever Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Classical Swine Fever Vaccines Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Classical Swine Fever Vaccines Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Classical Swine Fever Vaccines Sales by Type
  6. 5.2.1 Global Classical Swine Fever Vaccines Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Classical Swine Fever Vaccines Sales by Type (2021-2032) & (M Doses)
  8. 5.2.3 Global Classical Swine Fever Vaccines Sales Market Share by Type (2021-2032)
  9. 5.3 Global Classical Swine Fever Vaccines Price by Type
6 Classical Swine Fever Vaccines Market by Application
  1. 6.1 Global Classical Swine Fever Vaccines Revenue by Application
  2. 6.1.1 Global Classical Swine Fever Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Classical Swine Fever Vaccines Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Classical Swine Fever Vaccines Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Classical Swine Fever Vaccines Sales by Application
  6. 6.2.1 Global Classical Swine Fever Vaccines Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Classical Swine Fever Vaccines Sales by Application (2021-2032) & (M Doses)
  8. 6.2.3 Global Classical Swine Fever Vaccines Sales Market Share by Application (2021-2032)
  9. 6.3 Global Classical Swine Fever Vaccines Price by Application
7 Company Profiles
  1. 7.1 WINSUN
  2. 7.1.1 WINSUN Company Information
  3. 7.1.2 WINSUN Business Overview
  4. 7.1.3 WINSUN Classical Swine Fever Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 WINSUN Classical Swine Fever Vaccines Product Portfolio
  6. 7.1.5 WINSUN Recent Developments
  7. 7.2 Merial
  8. 7.2.1 Merial Company Information
  9. 7.2.2 Merial Business Overview
  10. 7.2.3 Merial Classical Swine Fever Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Merial Classical Swine Fever Vaccines Product Portfolio
  12. 7.2.5 Merial Recent Developments
  13. 7.3 CAHIC
  14. 7.3.1 CAHIC Company Information
  15. 7.3.2 CAHIC Business Overview
  16. 7.3.3 CAHIC Classical Swine Fever Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 CAHIC Classical Swine Fever Vaccines Product Portfolio
  18. 7.3.5 CAHIC Recent Developments
  19. 7.4 Chopper Biology
  20. 7.4.1 Chopper Biology Company Information
  21. 7.4.2 Chopper Biology Business Overview
  22. 7.4.3 Chopper Biology Classical Swine Fever Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Chopper Biology Classical Swine Fever Vaccines Product Portfolio
  24. 7.4.5 Chopper Biology Recent Developments
  25. 7.5 MSD Animal Health (Merck)
  26. 7.5.1 MSD Animal Health (Merck) Company Information
  27. 7.5.2 MSD Animal Health (Merck) Business Overview
  28. 7.5.3 MSD Animal Health (Merck) Classical Swine Fever Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 MSD Animal Health (Merck) Classical Swine Fever Vaccines Product Portfolio
  30. 7.5.5 MSD Animal Health (Merck) Recent Developments
  31. 7.6 ChengDu Tecbond
  32. 7.6.1 ChengDu Tecbond Company Information
  33. 7.6.2 ChengDu Tecbond Business Overview
  34. 7.6.3 ChengDu Tecbond Classical Swine Fever Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 ChengDu Tecbond Classical Swine Fever Vaccines Product Portfolio
  36. 7.6.5 ChengDu Tecbond Recent Developments
  37. 7.7 Ceva
  38. 7.7.1 Ceva Company Information
  39. 7.7.2 Ceva Business Overview
  40. 7.7.3 Ceva Classical Swine Fever Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Ceva Classical Swine Fever Vaccines Product Portfolio
  42. 7.7.5 Ceva Recent Developments
  43. 7.8 Harbin Veterinary Research Institute
  44. 7.8.1 Harbin Veterinary Research Institute Company Information
  45. 7.8.2 Harbin Veterinary Research Institute Business Overview
  46. 7.8.3 Harbin Veterinary Research Institute Classical Swine Fever Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Harbin Veterinary Research Institute Classical Swine Fever Vaccines Product Portfolio
  48. 7.8.5 Harbin Veterinary Research Institute Recent Developments
  49. 7.9 Qilu Animal Health Products Factory
  50. 7.9.1 Qilu Animal Health Products Factory Company Information
  51. 7.9.2 Qilu Animal Health Products Factory Business Overview
  52. 7.9.3 Qilu Animal Health Products Factory Classical Swine Fever Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Qilu Animal Health Products Factory Classical Swine Fever Vaccines Product Portfolio
  54. 7.9.5 Qilu Animal Health Products Factory Recent Developments
  55. 7.10 Ringpu Biology
  56. 7.10.1 Ringpu Biology Company Information
  57. 7.10.2 Ringpu Biology Business Overview
  58. 7.10.3 Ringpu Biology Classical Swine Fever Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Ringpu Biology Classical Swine Fever Vaccines Product Portfolio
  60. 7.10.5 Ringpu Biology Recent Developments
  61. 7.11 DHN
  62. 7.11.1 DHN Company Information
  63. 7.11.2 DHN Business Overview
  64. 7.11.3 DHN Classical Swine Fever Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 DHN Classical Swine Fever Vaccines Product Portfolio
  66. 7.11.5 DHN Recent Developments
  67. 7.12 CAVAC
  68. 7.12.1 CAVAC Company Information
  69. 7.12.2 CAVAC Business Overview
  70. 7.12.3 CAVAC Classical Swine Fever Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 CAVAC Classical Swine Fever Vaccines Product Portfolio
  72. 7.12.5 CAVAC Recent Developments
  73. 7.13 Komipharm
  74. 7.13.1 Komipharm Company Information
  75. 7.13.2 Komipharm Business Overview
  76. 7.13.3 Komipharm Classical Swine Fever Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Komipharm Classical Swine Fever Vaccines Product Portfolio
  78. 7.13.5 Komipharm Recent Developments
  79. 7.14 Agrovet
  80. 7.14.1 Agrovet Company Information
  81. 7.14.2 Agrovet Business Overview
  82. 7.14.3 Agrovet Classical Swine Fever Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Agrovet Classical Swine Fever Vaccines Product Portfolio
  84. 7.14.5 Agrovet Recent Developments
  85. 7.15 Bioveta
  86. 7.15.1 Bioveta Company Information
  87. 7.15.2 Bioveta Business Overview
  88. 7.15.3 Bioveta Classical Swine Fever Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Bioveta Classical Swine Fever Vaccines Product Portfolio
  90. 7.15.5 Bioveta Recent Developments
  91. 7.16 Jinyu Bio-Technology
  92. 7.16.1 Jinyu Bio-Technology Company Information
  93. 7.16.2 Jinyu Bio-Technology Business Overview
  94. 7.16.3 Jinyu Bio-Technology Classical Swine Fever Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Jinyu Bio-Technology Classical Swine Fever Vaccines Product Portfolio
  96. 7.16.5 Jinyu Bio-Technology Recent Developments
  97. 7.17 Institutul Pasteur
  98. 7.17.1 Institutul Pasteur Company Information
  99. 7.17.2 Institutul Pasteur Business Overview
  100. 7.17.3 Institutul Pasteur Classical Swine Fever Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Institutul Pasteur Classical Swine Fever Vaccines Product Portfolio
  102. 7.17.5 Institutul Pasteur Recent Developments
  103. 7.18 MVP
  104. 7.18.1 MVP Company Information
  105. 7.18.2 MVP Business Overview
  106. 7.18.3 MVP Classical Swine Fever Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 MVP Classical Swine Fever Vaccines Product Portfolio
  108. 7.18.5 MVP Recent Developments
  109. 7.19 Tecon
  110. 7.19.1 Tecon Company Information
  111. 7.19.2 Tecon Business Overview
  112. 7.19.3 Tecon Classical Swine Fever Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Tecon Classical Swine Fever Vaccines Product Portfolio
  114. 7.19.5 Tecon Recent Developments
8 North America
  1. 8.1 North America Classical Swine Fever Vaccines Market Size by Source
  2. 8.1.1 North America Classical Swine Fever Vaccines Revenue by Source (2021-2032)
  3. 8.1.2 North America Classical Swine Fever Vaccines Sales by Source (2021-2032)
  4. 8.1.3 North America Classical Swine Fever Vaccines Price by Source (2021-2032)
  5. 8.2 North America Classical Swine Fever Vaccines Market Size by Sales Channel
  6. 8.2.1 North America Classical Swine Fever Vaccines Revenue by Sales Channel (2021-2032)
  7. 8.2.2 North America Classical Swine Fever Vaccines Sales by Sales Channel (2021-2032)
  8. 8.2.3 North America Classical Swine Fever Vaccines Price by Sales Channel (2021-2032)
  9. 8.3 North America Classical Swine Fever Vaccines Market Size by Country
  10. 8.3.1 North America Classical Swine Fever Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Classical Swine Fever Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Classical Swine Fever Vaccines Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Classical Swine Fever Vaccines Market Size by Source
  2. 9.1.1 Europe Classical Swine Fever Vaccines Revenue by Source (2021-2032)
  3. 9.1.2 Europe Classical Swine Fever Vaccines Sales by Source (2021-2032)
  4. 9.1.3 Europe Classical Swine Fever Vaccines Price by Source (2021-2032)
  5. 9.2 Europe Classical Swine Fever Vaccines Market Size by Sales Channel
  6. 9.2.1 Europe Classical Swine Fever Vaccines Revenue by Sales Channel (2021-2032)
  7. 9.2.2 Europe Classical Swine Fever Vaccines Sales by Sales Channel (2021-2032)
  8. 9.2.3 Europe Classical Swine Fever Vaccines Price by Sales Channel (2021-2032)
  9. 9.3 Europe Classical Swine Fever Vaccines Market Size by Country
  10. 9.3.1 Europe Classical Swine Fever Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Classical Swine Fever Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Classical Swine Fever Vaccines Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Classical Swine Fever Vaccines Market Size by Source
  2. 10.1.1 China Classical Swine Fever Vaccines Revenue by Source (2021-2032)
  3. 10.1.2 China Classical Swine Fever Vaccines Sales by Source (2021-2032)
  4. 10.1.3 China Classical Swine Fever Vaccines Price by Source (2021-2032)
  5. 10.2 China Classical Swine Fever Vaccines Market Size by Sales Channel
  6. 10.2.1 China Classical Swine Fever Vaccines Revenue by Sales Channel (2021-2032)
  7. 10.2.2 China Classical Swine Fever Vaccines Sales by Sales Channel (2021-2032)
  8. 10.2.3 China Classical Swine Fever Vaccines Price by Sales Channel (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Classical Swine Fever Vaccines Market Size by Source
  2. 11.1.1 Asia Classical Swine Fever Vaccines Revenue by Source (2021-2032)
  3. 11.1.2 Asia Classical Swine Fever Vaccines Sales by Source (2021-2032)
  4. 11.1.3 Asia Classical Swine Fever Vaccines Price by Source (2021-2032)
  5. 11.2 Asia Classical Swine Fever Vaccines Market Size by Sales Channel
  6. 11.2.1 Asia Classical Swine Fever Vaccines Revenue by Sales Channel (2021-2032)
  7. 11.2.2 Asia Classical Swine Fever Vaccines Sales by Sales Channel (2021-2032)
  8. 11.2.3 Asia Classical Swine Fever Vaccines Price by Sales Channel (2021-2032)
  9. 11.3 Asia Classical Swine Fever Vaccines Market Size by Country
  10. 11.3.1 Asia Classical Swine Fever Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Classical Swine Fever Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Classical Swine Fever Vaccines Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Classical Swine Fever Vaccines Market Size by Source
  2. 12.1.1 SAMEA Classical Swine Fever Vaccines Revenue by Source (2021-2032)
  3. 12.1.2 SAMEA Classical Swine Fever Vaccines Sales by Source (2021-2032)
  4. 12.1.3 SAMEA Classical Swine Fever Vaccines Price by Source (2021-2032)
  5. 12.2 SAMEA Classical Swine Fever Vaccines Market Size by Sales Channel
  6. 12.2.1 SAMEA Classical Swine Fever Vaccines Revenue by Sales Channel (2021-2032)
  7. 12.2.2 SAMEA Classical Swine Fever Vaccines Sales by Sales Channel (2021-2032)
  8. 12.2.3 SAMEA Classical Swine Fever Vaccines Price by Sales Channel (2021-2032)
  9. 12.3 SAMEA Classical Swine Fever Vaccines Market Size by Country
  10. 12.3.1 SAMEA Classical Swine Fever Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Classical Swine Fever Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Classical Swine Fever Vaccines Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Classical Swine Fever Vaccines Value Chain Analysis
  2. 13.1.1 Classical Swine Fever Vaccines Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Classical Swine Fever Vaccines Production Mode & Process
  6. 13.2 Classical Swine Fever Vaccines Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Classical Swine Fever Vaccines Distributors
  9. 13.2.3 Classical Swine Fever Vaccines Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst